Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 2020 Research article · 2015 Detection of Circulating Tumor DNA Moves Closer To Clinical Use
detection of circulating tumor DNA (ctDNA) has been studied over 30 years as a method to monitor response to antiproliferative therapies in oncologic patients and, recently, to identify somatic genomic
Research article · 30 Dec 2020 Detection of Plasma Circulating Tumor DNA in Ovarian Cancer and Its Clinical Significance
Other · 23 Jul 2016 Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
predictive biomarker assessment of tumor tissue has substantial limitations. Recent clinical studies of circulating tumor DNA suggest such DNA may be a paradigmchanging medium for the diagnosis and management ... have…
Conference abstract · 24 Apr 2017 Genetics in oncology, liquid biopsy and circulating tumor DNA
paraffin embedded. The most recent addition to our testing menu has been the circulating tumor DNA (ctDNA) panel, more commonly known as liquid biopsy. 'Liquid biopsies' could revolutionize cancer detection ... solid…
Editorial · 31 Mar 2025 Liquid Biopsy-Driven Early Detection of Esophageal and Colorectal Cancers via Circulating Tumor DNA Methylation Signatures
their ability to detect early-stage disease. Liquid biopsy, particularly the analysis of circulating tumor DNA (ctDNA), has emerged as a promising, non-invasive diagnostic tool for early cancer detection
Opinion · 27 Dec 2021 Analysis of Circulating Tumor DNA and Its Mutations
derived dna in the blood plasma of sufferers with lymphomas so known as circulating tumor DNA have the capability to change the manner wherein lymphoma is identified and managed
Short communication · 2017 Is Circulating Tumor DNA (Ctdna) Use Ready For Prime Time? Applications and Challenges of Ctdna in the Era of Precision Oncology
peripheral blood [1]. Cell-free DNA consists of noncancerous nucleic acids and circulating tumor DNA (ctDNA). The proportion of ctDNA depends on the tumor cell of origin and stage
Article · 30 Aug 2024 Circulating Tumor DNA Analysis Defining the Genomic Landscape of Paragangliomas and Pheochromocytomas
mutational difference and assess the feasibility of Next Generation Sequencing (NGS) testing by Circulating Tumor DNA (ctDNA) from patients with PGLs and PCCs. Methods: Molecular alterations in 46 plasma samples
Article · 5 Sep 2024 The Use of Circulating Tumor DNA in Cancers of Unknown Primary: A Review of the Literature
targeted and specific treatments. Although data are limited regarding the possible applications of circulating tumor DNA (ct-DNA) in CUP, they warrant further investigation
Conference abstract · 2019 Droplet-based digital PCR procedures and optimized NGS to track circulating tumor DNA in liquid biopsies: application to colorectal cancer patient follow-up
Tracking of circulating cell-free nucleic acids in body effluents has been
Perspective · 17 Sep 2025 Circulating Tumor DNA as a Non-Invasive Tool for Cancer Monitoring and Treatment Adjustment
Article · 30 Apr 2025 Circulating Tumor DNA as a Non-invasive Prognostic Tool in Cancer Management
Perspective · 5 Mar 2025 Circulating Tumor DNA as a Predictive Biomarker in Colorectal Cancer Treatment
Commentary · 28 Jun 2024 Emerging Role of Circulating Tumor DNA (ctDNA) in Cancer Management
Short communication · 29 Feb 2024 Prognostic Significance of Circulating Tumor DNA in Colorectal Cancer: A Meta-analysis
Short communication · 2024 The Contribution of Circulating Tumor DNA in Liquid Biopsy for Cancer Diagnosis
Mini review · 27 Jun 2023 Circulating Tumor DNA Analysis in Liquid Biopsy: Implications for Treatment Response and Resistance
Commentary · 31 Mar 2023 Circulating Tumor DNA for Detection and Evaluation of Metastatic Prostate Cancer
Editorial · 2021 A Circulating Tumor DNA
Opinion · 28 Mar 2025 Towards Blood-Based Biopsies: Challenges and Innovations in Liquid Biopsy Biomarkers
Review article · 30 May 2024 Revolutionizing Cancer Diagnosis: The Promise of Liquid Biopsy
circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and circulating tumor DNA (ctDNA), present in bodily fluids like blood, urine, and saliva. This technique offers several advantages…
Review article · 28 Aug 2023 Tumor DNA in the Circulating Bloodstream in Breast Cancer Current and Future Applications
presence of tumor DNA in the bloodstream, known as circulating tumor DNA (ctDNA), has emerged as a groundbreaking tool in breast cancer research and management. This article explores the current
Editorial · 29 Jul 2024 Non-invasive Diagnostic Instruments for Cancer Tracking: Liquid Biopsies
analyzing biomarkers such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), and exosomes in blood samples, liquid biopsies offer significant advantages over traditional tissue…

